The following information is missing from the Funding statement: This study was funded by a grant to Dr. Ahuja from Astex Inc. (GRANT # 120039).
There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: Dr. Ahuja receives research grant funding from Astex Inc. and the Van Andel Research Institute. She is a consultant for and has licensed methylation biomarkers to Cepheid (PATENT # 10167513). Dr. Ahuja has also served as consultant to Johnson and Johnson, an advisor to Celgene, and a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
The raw data underlying the findings of this study are missing from the list of Supporting Information. The authors have provided the data as Supporting Information file S1 Data. With this correction [1], all relevant data are now provided.
Reference
- 1. Sharma A, Vatapalli R, Abdelfatah E, McMahon K Wyatt, Kerner Z, A. Guzzetta A, et al. (2017) Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells. PLoS ONE 12(4): e0176139. https://doi.org/10.1371/journal.pone.0176139 pmid:28445481
Citation: Sharma A, Vatapalli R, Abdelfatah E, McMahon KW, Kerner Z, A. Guzzetta A, et al. (2020) Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells. PLoS ONE 15(11): e0242750. https://doi.org/10.1371/journal.pone.0242750
Published: November 30, 2020
Copyright: © 2020 Sharma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.